Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Nicholson

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Indian Journal of Ophthalmology|December 26, 2024
Ultrastructural imaging biomarkers in diabetic macular edema: A major reviewSagnik Sen, Hagar Khalid, Prithviraj Udaya, et al.
American Journal of Ophthalmology|October 29, 2015
ReplyLuke Nicholson, Clara Vazquez-Alfageme, Jayashree Ramu, et al.
Eye (London, England)|March 15, 2026
Clinical spectrum of intraocular inflammation following faricimab intravitreal injections: evidence from a large real-life cohort in the United KingdomGiuseppe Demarinis, Ian Yeung, Ella Preston, et al.
Survey of Ophthalmology|February 28, 2026
Update on subthreshold micropulse laser treatment for retinal diseases: A narrative reviewSing Yue Sim, Lik Thai Lim, Sameer Chaudhary, et al.
Journal of Virology|January 10, 2025
The pseudorabies virus UL13 protein kinase triggers phosphorylation of the RNA demethylase FTO, which is associated with FTO-dependent suppression of interferon-stimulated gene expressionRuth Verhamme, Robert J J Jansens, Jianheng Liu, et al.
The British Journal of Ophthalmology|April 21, 2026
Real-world early outcomes of intravitreal faricimab 6-mg and aflibercept 2-mg injection in diabetic macular oedemaEvangelia Chalkiadaki, Yue Sing Sim, Olayinka Williams, et al.
Investigative Ophthalmology & Visual Science|October 30, 2018
Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY SubstudyLuke Nicholson, Roxanne Crosby-Nwaobi, Joana C Vasconcelos, et al.
Retina (Philadelphia, Pa.)|January 6, 2025
INTRAOCULAR INFLAMMATION ASSOCIATED WITH FARICIMAB THERAPY: One-Year Real-World OutcomesAndrea Montesel, Sagnik Sen, Ella Preston, et al.
Eye (London, England)|January 26, 2020
Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degenerationShruti Chandra, Cristina Arpa, Deepthy Menon, et al.
JAMA Ophthalmology|March 11, 2021
Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical TrialSandra Halim, Manjula Nugawela, Usha Chakravarthy, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Indian Journal of Ophthalmology|December 26, 2024
Ultrastructural imaging biomarkers in diabetic macular edema: A major reviewSagnik Sen, Hagar Khalid, Prithviraj Udaya, et al.
American Journal of Ophthalmology|October 29, 2015
ReplyLuke Nicholson, Clara Vazquez-Alfageme, Jayashree Ramu, et al.
Eye (London, England)|March 15, 2026
Clinical spectrum of intraocular inflammation following faricimab intravitreal injections: evidence from a large real-life cohort in the United KingdomGiuseppe Demarinis, Ian Yeung, Ella Preston, et al.
Survey of Ophthalmology|February 28, 2026
Update on subthreshold micropulse laser treatment for retinal diseases: A narrative reviewSing Yue Sim, Lik Thai Lim, Sameer Chaudhary, et al.
Journal of Virology|January 10, 2025
The pseudorabies virus UL13 protein kinase triggers phosphorylation of the RNA demethylase FTO, which is associated with FTO-dependent suppression of interferon-stimulated gene expressionRuth Verhamme, Robert J J Jansens, Jianheng Liu, et al.
The British Journal of Ophthalmology|April 21, 2026
Real-world early outcomes of intravitreal faricimab 6-mg and aflibercept 2-mg injection in diabetic macular oedemaEvangelia Chalkiadaki, Yue Sing Sim, Olayinka Williams, et al.
Investigative Ophthalmology & Visual Science|October 30, 2018
Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY SubstudyLuke Nicholson, Roxanne Crosby-Nwaobi, Joana C Vasconcelos, et al.
Retina (Philadelphia, Pa.)|January 6, 2025
INTRAOCULAR INFLAMMATION ASSOCIATED WITH FARICIMAB THERAPY: One-Year Real-World OutcomesAndrea Montesel, Sagnik Sen, Ella Preston, et al.
Eye (London, England)|January 26, 2020
Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degenerationShruti Chandra, Cristina Arpa, Deepthy Menon, et al.
JAMA Ophthalmology|March 11, 2021
Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical TrialSandra Halim, Manjula Nugawela, Usha Chakravarthy, et al.
Pageof 8